Generic placeholder image

Current Psychiatry Reviews

Editor-in-Chief

ISSN (Print): 1573-4005
ISSN (Online): 1875-6441

Psychiatric Advance Directives: Benefits and Barriers

Author(s): Anna Scheyett

Volume 4 , Issue 3 , 2008

Page: [137 - 144] Pages: 8

DOI: 10.2174/157340008785829940

Price: $65

Abstract

Evidence is reviewed here which suggests that antiepileptic drugs (AEDs) may be effective for the treatment of impulsivity across a range of psychiatric disorders and for impulse control and cluster B personality disorders in particular. AEDs may be effective for the treatment of the brain circuitry related to impulsivity, by modulating GABA, glutamate, serotonin, and norepinephrine. It is suggested that interventions should be directed at the brain circuitry which modulates core symptoms like impulsivity that may be shared across disorders, rather than the disorder itself. In addition to these core symptom domains, clinicians should identify comorbid conditions and associated symptoms related to brain systems as they can also influence overall treatment response. The increasing experience of psychiatrists in treating impulse control disorders, cluster B personality disorders, and impulsivity across disorders should complement the knowledge obtained from research. This will lead to a better understanding of the brain mechanisms underlying impulsive symptom domains within disorders and to more targeted treatments with improved outcomes.

Keywords: Psychiatric advance directives, serious mental illness, autonomy, crisis, legal, advance statements


Rights & Permissions Print Export Cite as
© 2022 Bentham Science Publishers | Privacy Policy